![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
60
PharmaCompass offers a list of Bremelanotide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bremelanotide manufacturer or Bremelanotide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bremelanotide manufacturer or Bremelanotide supplier.
PharmaCompass also assists you with knowing the Bremelanotide API Price utilized in the formulation of products. Bremelanotide API Price is not always fixed or binding as the Bremelanotide Price is obtained through a variety of data sources. The Bremelanotide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bremelanotide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bremelanotide, including repackagers and relabelers. The FDA regulates Bremelanotide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bremelanotide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bremelanotide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bremelanotide supplier is an individual or a company that provides Bremelanotide active pharmaceutical ingredient (API) or Bremelanotide finished formulations upon request. The Bremelanotide suppliers may include Bremelanotide API manufacturers, exporters, distributors and traders.
click here to find a list of Bremelanotide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bremelanotide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bremelanotide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bremelanotide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bremelanotide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bremelanotide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bremelanotide suppliers with NDC on PharmaCompass.
Bremelanotide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bremelanotide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bremelanotide GMP manufacturer or Bremelanotide GMP API supplier for your needs.
A Bremelanotide CoA (Certificate of Analysis) is a formal document that attests to Bremelanotide's compliance with Bremelanotide specifications and serves as a tool for batch-level quality control.
Bremelanotide CoA mostly includes findings from lab analyses of a specific batch. For each Bremelanotide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bremelanotide may be tested according to a variety of international standards, such as European Pharmacopoeia (Bremelanotide EP), Bremelanotide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bremelanotide USP).